Petmed Express (PETS) Cost of Revenue (2016 - 2025)
Petmed Express' Cost of Revenue history spans 16 years, with the latest figure at $31.2 million for Q4 2025.
- For Q4 2025, Cost of Revenue fell 12.91% year-over-year to $31.2 million; the TTM value through Dec 2025 reached $135.5 million, down 19.46%, while the annual FY2025 figure was $157.8 million, 16.63% down from the prior year.
- Cost of Revenue reached $31.2 million in Q4 2025 per PETS's latest filing, down from $31.9 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $57.5 million in Q2 2021 to a low of $31.2 million in Q4 2025.
- Average Cost of Revenue over 5 years is $43.2 million, with a median of $43.6 million recorded in 2022.
- Peak YoY movement for Cost of Revenue: rose 12.45% in 2024, then fell 22.64% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $43.0 million in 2021, then decreased by 5.41% to $40.7 million in 2022, then grew by 8.81% to $44.2 million in 2023, then decreased by 19.03% to $35.8 million in 2024, then decreased by 12.91% to $31.2 million in 2025.
- Per Business Quant, the three most recent readings for PETS's Cost of Revenue are $31.2 million (Q4 2025), $31.9 million (Q3 2025), and $36.8 million (Q2 2025).